INSULIN ANTIBODY-RESPONSES AFTER LONG-TERM INTRAPERITONEAL INSULIN USE DURING IMPLANTABLE PROGRAMMABLE INSULIN DELIVERY

被引:0
|
作者
OLSEN, C [1 ]
CHARLES, MA [1 ]
DUNN, F [1 ]
NATHAN, D [1 ]
SCAVINI, M [1 ]
SELAM, JL [1 ]
CHAN, E [1 ]
机构
[1] UNIV CALIF IRVINE,IRVINE,CA 92717
来源
CLINICAL RESEARCH | 1993年 / 41卷 / 01期
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:A46 / A46
页数:1
相关论文
共 50 条
  • [1] INSULIN ANTIBODY-RESPONSES AFTER LONG-TERM INTRAPERITONEAL INSULIN ADMINISTRATION VIA IMPLANTABLE PROGRAMMABLE INSULIN DELIVERY SYSTEMS
    OLSEN, CL
    CHAN, E
    TURNER, DS
    IRAVANI, M
    NAGY, M
    SELAM, JL
    WONG, ND
    WAXMAN, K
    CHARLES, MA
    [J]. DIABETES CARE, 1994, 17 (03) : 169 - 176
  • [2] LONG-TERM INTRAPERITONEAL INSULIN DELIVERY
    PITT, HA
    SAUDEK, CD
    ZACUR, HA
    [J]. ANNALS OF SURGERY, 1992, 216 (04) : 483 - 492
  • [3] INTRAPERITONEAL INSULIN ABSORPTION AFTER LONG-TERM INTRAPERITONEAL INSULIN THERAPY
    SCAVINI, M
    ZAGER, PG
    PINCELLI, A
    TORRI, M
    PETRELLA, G
    POZZA, G
    GALIMBERTI, G
    [J]. DIABETES CARE, 1995, 18 (01) : 56 - 59
  • [4] LONG-TERM SAFETY AND EFFICACY OF PROGRAMMABLE IMPLANTABLE INSULIN DELIVERY SYSTEMS
    OLSEN, CL
    LIU, G
    IRAVANI, M
    NGUYEN, S
    KHOURDADJIAN, K
    TURNER, DS
    WAXMAN, K
    SELAM, JL
    CHARLES, MA
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1993, 16 (12): : 847 - 854
  • [5] IMMUNOGENICITY OF LONG-TERM INTRAPERITONEAL INSULIN ADMINISTRATION WITH IMPLANTABLE PROGRAMMABLE PUMPS - METABOLIC CONSEQUENCES
    LASSMANNVAGUE, V
    BELICAR, P
    RACCAH, D
    VIALETTES, B
    SODOYEZ, JC
    VAGUE, P
    [J]. DIABETES CARE, 1995, 18 (04) : 498 - 503
  • [6] INSULIN ANTIBODY-LEVELS AFTER 2-3 YEARS OF INTRAPERITONEAL OR INTRAVENOUS INSULIN USING IMPLANTABLE INSULIN DELIVERY
    CHARLES, MA
    DUNN, F
    NATHAN, D
    SCAVINI, M
    [J]. DIABETOLOGIA, 1993, 36 : A161 - A161
  • [7] INSULIN STABILITY AND IMMUNOGENICITY DURING LONG-TERM INTRAPERITONEAL IMPLANTABLE PROGRAMMABLE PUMP TREATMENT IN TYPE-I DIABETES
    JEANDIDIER, N
    SELAM, JL
    SAUDEK, CD
    NAGY, M
    ZOLTOBROCKI, M
    CHARLES, MA
    [J]. CLINICAL RESEARCH, 1989, 37 (01): : A159 - A159
  • [8] INSULIN ANTIBODY FORMATION DURING LONG-TERM TREATMENT WITH MONOCOMPONENT AND MONOSPECIES INSULIN
    PIERS, DA
    SLUITER, WJ
    REITSMA, WD
    DOORENBOS, H
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 1974, 17 (4-5): : 234 - 238
  • [9] ALTERATIONS IN REVERSE CHOLESTEROL TRANSPORT ASSOCIATED WITH PROGRAMMABLE IMPLANTABLE INTRAPERITONEAL INSULIN DELIVERY
    SELAM, JL
    KASHYAP, ML
    GUPTA, AK
    TURNER, D
    WONG, ND
    LOZANO, JL
    CHARLES, MA
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1994, 43 (06): : 665 - 669
  • [10] INTRAPERITONEAL ABSORPTION OF INSULIN AFTER LONG-TERM INSULIN THERAPY IN TYPE-1 DIABETICS
    PINCELLI, A
    SCAVINI, M
    TORRI, M
    MICOSSI, P
    POZZA, G
    [J]. DIABETOLOGIA, 1992, 35 : A196 - A196